- July 14, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC") , a publicly traded wellness company focused on advanced peptide formulations and delivery systems, today announces that it has received its production run of approximately 20,000 units of its BPC-157 transdermal patch (the "Patch"), the Company's lead product candidate
Symptoms include metabolic acidosis, Central Nervous System depression, and respiratory distress
Neurotransmitter Synthesis B12 enables creation of feel good chemicals for mood like serotonin, dopamine, and norepinephrine
The procedure is generally quick and performed in a clinic setting, using local anesthesia to minimize discomfort
This allows assessment of healing response while minimizing any potential side effects
These can cause reactions too